Sleep

Which aspects of sleep are relevant to strength training

For strength athletes, sleep is not a single metric. Bedtime, actual duration of sleep, sleep architecture, hormonal signals, metabolism and functional outcomes all provide answers to different questions. A change in a biomarker is therefore not automatically evidence of increased muscle mass, strength or better recovery.

The controlled human studies analysed primarily examine a brief reduction in time spent in bed, acute sleep deprivation, the reduction of short-wavelength light before bedtime, and a single dose of caffeine. There is no direct investigation of sleep prolongation in resistance-trained athletes using muscle protein synthesis, hypertrophy or recovery endpoints. Similarly, there is no direct comparison testing sleep against diet or supplementation as a recovery variable. It is therefore not possible to derive a ranking of these factors from these findings.

What a short reduction in bedtime measurably changes

Insulin sensitivity

A randomised crossover study in humans involving 14 healthy, lean adults compared five nights with four hours’ sleep per night, rather than eight, following two nights of acclimatisation. Whole-body insulin sensitivity fell by 25 per cent, and peripheral insulin sensitivity by 29 per cent; hepatic insulin sensitivity did not change significantly.

These are metabolic endpoints. The study did not include any muscle- or performance-related endpoints. Consequently, the changes in insulin sensitivity do not provide any specific insights into muscle growth, strength or optimal sleep duration.

Cortisol: a context-dependent finding

In the same report, free cortisol in the 24-hour urine sample rose by 21 per cent during the short period of restriction. This finding stems from a brief, severe reduction in sleep duration and a single urine sample. It does not indicate either a persistently elevated daily profile or a necessary effect of cortisol on muscle recovery.

A systematic review and meta-analysis of acute sleep deprivation assessed 24 studies. In 21 crossover studies and three randomised trials, the overall effect on cortisol was not significant. For the crossover data, the standardised mean difference was 0.18, with a 95 per cent confidence interval of −0.11 to 0.45; and for the randomised trials, it was 0.26 with a 95 per cent confidence interval of −0.22 to 0.73. Increases were observed in subgroups with serum samples or multiple measurements.

The findings thus show that the protocol, duration, measurement equipment and time of measurement all influence the interpretation. They do not indicate a universal daily cortisol rhythm, nor do they support a general conclusion that any form of sleep deprivation leads to a permanently elevated cortisol level.

Where the hormonal and muscular chain ends

The quantitative claim that a fixed proportion of daily growth hormone (GH) secretion is released during the first stage of deep sleep, shortly after falling asleep, has not been substantiated with this level of precision. Nor has the conclusion that an altered sleep-related GH pulse leads to poorer recovery or a less favourable body composition been demonstrated in long-term studies.

A GH pulse can be described as a marker of sleep physiology. Even if such a pulse is observed, this does not provide direct evidence in humans of long-term hypertrophy, increased strength or a specific body composition.

The studies on reduced sleep duration and acute sleep deprivation measured insulin sensitivity and cortisol, respectively, but not muscle protein synthesis (MPS), muscle mass or strength. The light-reduction interventions and the caffeine study used sleep parameters as their endpoints, rather than muscle mass, strength or other muscular recovery endpoints.

The question regarding MPS remains open. There is insufficient evidence to reliably conclude that myofibrillar protein synthesis (MyoPS) is reduced, that it remains at control levels during high-intensity interval training (HIIT), or that there is no change in signalling markers. A halving of the MPS response and a general recommendation for HIIT to compensate for sleep restriction are therefore not supported by the evidence. Even a possible finding in favour of HIIT would not constitute a direct test of resistance training.

Nor does the sleep architecture in this brief protocol provide clear evidence of a shortened deep sleep phase: in the study, the number of minutes spent in N3 sleep – a deep sleep phase – did not differ significantly between four and eight hours of bedtime. This finding applies only to the five days of sleep restriction and the protocol under investigation.

What specific sleep rules actually reveal

Screens and short-wavelength light

A systematic review and meta-analysis of 12 studies examined various interventions aimed at reducing exposure to short-wavelength light before bedtime. The study populations were heterogeneous; tinted filter glasses were frequently used, rather than standardised screen abstinence. For objective sleep efficiency, the pooled effect was small to moderate, but the 95 per cent confidence interval included a zero effect: Hedges’ g 0.31, 95 per cent confidence interval −0.05 to 0.66, seven studies. Objective total sleep time was slightly higher in six studies: Hedges’ g 0.32, 95 per cent confidence interval 0.01 to 0.63.

The results therefore do not justify a universal rule to avoid all screens for an hour before going to sleep. The interventions did not fully distinguish between short-wavelength light, device use and a later bedtime. Furthermore, they did not include any muscle, strength or recovery-related outcomes. Nor can it be inferred from this that the effect of sleep is less than that of melatonin.

Caffeine

In a randomised, placebo-controlled human study using a crossover design, 400 milligrams of caffeine were taken either zero, three or six hours before going to bed. All three timing points significantly disrupted sleep compared with the placebo; even a six-hour interval led to a significant reduction in total sleep time.

This is an acute finding relating to a high single dose. It does not justify a universal caffeine cut-off of six to eight hours, nor a general half-life applicable to all individuals. Dose, tolerance and individual pharmacokinetics limit the generalisability of these findings.

Room temperature, sleeping patterns and supplements

An optimal room temperature of 16 to 19 degrees Celsius has not been established as a proven target range. There is also a lack of robust intervention literature directly linking consistent sleep times in strength athletes to muscle growth or recovery.

There is no robust evidence from studies involving athletes or focusing on muscle and recovery outcomes to support the specific combination of three grams of glycine and 300 milligrams of magnesium taken before bed. It should therefore not be presented as an evidence-based standard for sleep, muscle building or recovery. The lack of suitable evidence does not prove that it is ineffective, but it does not allow for a robust recommendation.

What can be cautiously inferred from the findings

Shown directly: A sharp, brief reduction in bedtime can alter metabolic and hormonal readings under the protocol studied. This is not a dosage recommendation and does not specify an optimal duration of sleep.

A cautious derivation: Caffeine should not automatically be considered to have no effect on sleep if a high single dose is taken six hours before going to bed. Where short-wavelength light is reduced, individual testing is possible, but these sleep data do not support a fixed one-hour rule.

Not documented: Neither a single GH or cortisol marker, nor a specific room temperature or combination of supplements, can replace functional endpoints such as strength, muscle mass or actual recovery.

Why the issue of extended sleep duration in athletes remains unresolved

In practice, the key research question would be whether increasing sleep duration in athletes who undergo resistance training improves muscle protein synthesis (MPS), hypertrophy or recovery. There are currently no convincing controlled human studies available that examine these endpoints. Consequently, it is not possible to specify either an additional number of hours or any expected effect on muscle or performance.

There is also no direct comparison of sleep with diet or supplementation. Age, gender, training status, energy availability, calorie deficit, baseline sleep, chronotype and individual caffeine tolerance have not been adequately examined as moderating factors when it comes to applying these findings to bodybuilders.

Classification

Short-term, severe sleep restriction, when carried out under controlled conditions, can impair insulin sensitivity and increase 24-hour urinary cortisol levels. By contrast, a meta-analysis on acute sleep deprivation found no significant overall difference in cortisol levels. The objective conclusion is therefore that sleep is a measurable variable in terms of training and health, but the available evidence does not support the notion that it takes precedence over diet and supplements, nor does it demonstrate an automatic link between sleep markers and muscle growth. Precise guidelines regarding growth hormone, room temperature, avoiding screen time, caffeine, or glycine and magnesium remain context-dependent or unresolved.

This article was created using AI systems. Find out more